NCT01878123 - Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

AMP-110

Dose levels 1 through 7: Single intravenous infusion on Day 0

OTHER

Placebo

Dose levels 4 through 7: Single intravenous infusion on Day 0

Trial Locations (3)

Altoona Center for Clinical Research, Duncansville

Pinnacle Research Group, LLC, Anniston

Metroplex Clinical Research Center, Dallas